Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Bone Biologics (BBLGW) Long-Term Debt Issuances (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $700000.0 as the latest value for Q3 2017.

  • Quarterly Long-Term Debt Issuances changed N/A to $700000.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2017, down 12.43% year-over-year, with the annual reading at $1.8 million for FY2024, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q3 2017 was $700000.0 at Bone Biologics, down from $2.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $2.0 million in Q1 2017, with the low at $700000.0 in Q3 2017.